Cargando…
Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel
BACKGROUND: The administration of antiplatelet drugs before coronary artery bypass graft surgery (CABG) is associated with an increased risk of major hemorrhage and related surgical reexploration. Little is known about the relative effect of combined clopidogrel and aspirin on blood product use arou...
Autores principales: | Ray, Joel G, Deniz, Stacy, Olivieri, Anthony, Pollex, Erika, Vermeulen, Marian J, Alexander, Kurian S, Cain, David J, Cybulsky, Irene, Hamielec, Cindy M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC162165/ https://www.ncbi.nlm.nih.gov/pubmed/12769833 http://dx.doi.org/10.1186/1471-2261-3-3 |
Ejemplares similares
-
Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004) -
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005) -
Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery
por: Wang, Xuezhong, et al.
Publicado: (2014) -
Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021) -
Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
por: Dalmau, Maria J, et al.
Publicado: (2015)